Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Healthcare Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Bullboard (TSX:OPS)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Possibleidiot01on Apr 23, 2023 6:59pm

RE:Price targets

We've been seeing a series of minor target reductions and limited share volume recently and a cheap stock price. My feeling is it's all related to cash being used in introducing SavvyWire ...more  
159
Discussion
Post by WhiteknightAon Apr 23, 2023 11:27am

Price targets

I've been a shareholder of ops for some time, I've bought around 2 bucks. I've followed some of the news specific to the price targets and have noticed that raymon James has been calling ...more  
219
Discussion
Post by ivebeenthereon Apr 20, 2023 10:04pm

Short Notice

The last time they gave such a short notice that they were going to be participating in a conference was september 14th 2022 and it was to say that the Savvywire was FDA Approved . Things are coming ...more  
181
Post by retiredcfon Apr 18, 2023 9:27am

RBC Follow Up Report

Their upside scenario target remains $5.00. GLTA April 13, 2023 Outperform Speculative Risk TSX: OPS; CAD 1.79 Price Target CAD 3.50 ...more  
188
Post by Possibleidiot01on Apr 13, 2023 6:17pm

Raymond James - cantechletter.com

By Jayson MacLean Published on April 13, 2023 Last Updated on April 13, 2023 Filed under:   All posts, Analysts, Health Stock:   ops OpSens is over a double ...more  
280
Post by ivebeenthereon Apr 13, 2023 5:34pm

winning market share

Seeing how fast they gain market share. In just 2 months they gained 35 to 50% I just dont see how the big medical device company can compete,they can't start a price war because their device is ...more  
218
Post by bossuon Apr 13, 2023 4:06pm

Top line revenue in the coming nexrt 2 quarters

Probably a double digit %revenue  in the next  2 quarters and Q3 to be $ 10,8 M x 11o % or $ 12.0M and Q4 $ 12,o X 110% or $ 13 M or $ 25 M for the H2 compare to $ 19 M in the H1 A high ...more  
143
Post by ivebeenthereon Apr 13, 2023 12:15pm

% of interventions

M. Laflamme said that in the Cath labs that have been adopting the Savvywire for 2 months  the percentage of the interventions done with the Savvywire is from 35 to 50%. RBC's analyst was ...more  
200
Comment by Nadia6519on Apr 13, 2023 12:12pm

RE:Nice Early Headfake

No doubt this company has potential and today's results confirm that.  I am surprised by the low volume...  We will probably read a couple of other analyts' comments in the coming ...more  
72
Discussion
Post by retiredcfon Apr 13, 2023 11:47am

Nice Early Headfake

For the first half hour, the SP gave the impression of a muted to negative response to the earnings on low trading volume. But now the larger trades (relatively speaking) are showing up and beginning ...more  
176
Discussion
Post by retiredcfon Apr 13, 2023 8:27am

RBC Reaction

April 13, 2023 Opsens Inc. FQ2/23: Results ahead of estimates; focus on SavvyWire ramp-up TSX: OPS | CAD 1.66 | Outperform | Speculative Risk | Price Target CAD 3.50 ...more  
189
Comment by Possibleidiot01on Apr 13, 2023 7:50am

RE:RE:RBC Report

Going to use your numbers. so $29 million. Cash at February 28 - $21.9 million. $7.1 million cash burn. $2.9 million used for sales and marketing . Structural heart sales, despite being in controlled ...more  
101
Discussion
Post by bossuon Apr 12, 2023 9:11pm

Just want to give a ''booster'' to Mr Laflamme

He may need yo have a  ''Zopiclone''  pill to have a good night...to explain tomorrow his  strategy for the coming months. May be 2000 procedures by July 3 ..... Just to ...more  
117
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities